Dr Ulrich Granzer

Granzer Regulatory Consulting & Services is a specialized consultancy providing strategic regulatory and clinical development support to the global pharmaceutical and biotech industries. Founded in 2002 by Dr. Ulrich Granzer, the firm assists clients in navigating complex regulatory landscapes, including interactions with the EMA and FDA. Their expertise covers a broad spectrum of products, from small molecules to advanced therapies like gene and cell products. The company offers services such as preparation of briefing documents, orphan drug applications, and management of marketing authorization procedures. Based in Munich, they are recognized for their deep technical knowledge and successful track record in drug approvals.